End-of-day quote
Korea S.E.
23:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
4,800
KRW
|
+0.31%
|
|
0.00%
|
+18.37%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
102,428
|
92,158
|
137,258
|
142,452
|
93,171
|
104,079
|
Enterprise Value (EV)
1 |
23,281
|
30,711
|
67,675
|
58,427
|
14,354
|
-429.1
|
P/E ratio
|
10.3
x
|
51.9
x
|
94.9
x
|
7.01
x
|
-1.95
x
|
2.37
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.21
x
|
1.15
x
|
1.67
x
|
1.42
x
|
0.99
x
|
0.84
x
|
EV / Revenue
|
0.28
x
|
0.38
x
|
0.82
x
|
0.58
x
|
0.15
x
|
-0
x
|
EV / EBITDA
|
1.36
x
|
10.1
x
|
7.17
x
|
3.38
x
|
-0.6
x
|
-0.01
x
|
EV / FCF
|
2.1
x
|
10.9
x
|
5.54
x
|
5.83
x
|
-1.09
x
|
-0.02
x
|
FCF Yield
|
47.6%
|
9.15%
|
18.1%
|
17.2%
|
-91.4%
|
-5,565%
|
Price to Book
|
0.74
x
|
0.66
x
|
0.98
x
|
0.77
x
|
0.65
x
|
0.55
x
|
Nbr of stocks (in thousands)
|
22,914
|
22,811
|
22,687
|
25,667
|
25,667
|
25,667
|
Reference price
2 |
4,470
|
4,040
|
6,050
|
5,550
|
3,630
|
4,055
|
Announcement Date
|
20/03/19
|
18/03/20
|
18/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
84,441
|
80,312
|
82,039
|
100,199
|
93,816
|
123,383
|
EBITDA
1 |
17,078
|
3,045
|
9,440
|
17,262
|
-23,740
|
34,612
|
EBIT
1 |
13,936
|
275.2
|
7,152
|
14,743
|
-26,476
|
31,821
|
Operating Margin
|
16.5%
|
0.34%
|
8.72%
|
14.71%
|
-28.22%
|
25.79%
|
Earnings before Tax (EBT)
1 |
11,433
|
6,379
|
7,060
|
33,895
|
-45,344
|
54,123
|
Net income
1 |
9,935
|
1,779
|
1,447
|
17,822
|
-41,712
|
38,249
|
Net margin
|
11.77%
|
2.21%
|
1.76%
|
17.79%
|
-44.46%
|
31%
|
EPS
2 |
433.5
|
77.91
|
63.76
|
792.1
|
-1,864
|
1,714
|
Free Cash Flow
1 |
11,089
|
2,809
|
12,220
|
10,022
|
-13,124
|
23,882
|
FCF margin
|
13.13%
|
3.5%
|
14.9%
|
10%
|
-13.99%
|
19.36%
|
FCF Conversion (EBITDA)
|
64.93%
|
92.24%
|
129.44%
|
58.06%
|
-
|
69%
|
FCF Conversion (Net income)
|
111.62%
|
157.9%
|
844.29%
|
56.24%
|
-
|
62.44%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/03/19
|
18/03/20
|
18/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
79,147
|
61,447
|
69,583
|
84,025
|
78,817
|
104,509
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
11,089
|
2,809
|
12,220
|
10,022
|
-13,124
|
23,882
|
ROE (net income / shareholders' equity)
|
6.02%
|
3.2%
|
2.79%
|
14.8%
|
-20.8%
|
23.7%
|
ROA (Net income/ Total Assets)
|
4.53%
|
0.08%
|
2.1%
|
3.89%
|
-6.94%
|
8.01%
|
Assets
1 |
219,402
|
2,097,647
|
68,962
|
458,266
|
600,869
|
477,455
|
Book Value Per Share
2 |
6,056
|
6,144
|
6,169
|
7,189
|
5,551
|
7,384
|
Cash Flow per Share
2 |
798.0
|
1,000
|
1,821
|
700.0
|
1,489
|
675.0
|
Capex
1 |
439
|
1,651
|
1,201
|
804
|
476
|
662
|
Capex / Sales
|
0.52%
|
2.06%
|
1.46%
|
0.8%
|
0.51%
|
0.54%
|
Announcement Date
|
20/03/19
|
18/03/20
|
18/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +18.37% | 91.04M | | -2.78% | 15.11B | | -37.28% | 2.88B | | -12.11% | 2.48B | | -14.23% | 1.43B | | -.--% | 1.12B | | +66.72% | 614M | | +90.77% | 509M | | +18.98% | 260M | | -2.35% | 227M |
Medical Imaging Systems
|